Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DermTech Inc DMTKQ

Healthcare Biotechnology
DermTech, Inc. is a molecular diagnostic company. The Company is engaged in developing and marketing non-invasive genomics tests to aid in the diagnosis and management of melanoma. Its technology enhances evaluation of lesions suspicious for melanoma using non-invasive sample collection and detecting genomic markers associated with melanoma to identify higher risk lesions or rule out melanoma... see more

Recent & Breaking News (OTCPK:DMTKQ)

DermTech Files for Voluntary Chapter 11 Protection

Business Wire 13 days ago

DermTech Reports First-Quarter 2024 Financial Results

Business Wire May 14, 2024

DermTech to Explore Strategic Alternatives and Implement Restructuring Plan

Business Wire April 18, 2024

DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire April 1, 2024

DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology

Business Wire March 8, 2024

DermTech Reports Fourth-Quarter 2023 Financial Results

Business Wire February 29, 2024

DermTech Announces Release Date for Fourth-quarter 2023 Financial Results

Business Wire February 13, 2024

DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations

Business Wire January 31, 2024

DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types

Business Wire January 18, 2024

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

Business Wire January 16, 2024

DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)

Business Wire January 8, 2024

DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Business Wire December 28, 2023

INVESTOR ALERT: Levi & Korsinsky Reminds DermTech, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2023 - DMTK

Accesswire December 15, 2023

DEADLINE TODAY: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses of $100,000 to Contact the Firm

Newsfile December 15, 2023

SHAREHOLDER ALERT: Potential Recovery for DermTech, Inc. (DMTK) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit

Accesswire December 15, 2023

DMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - DMTK

Business Wire December 15, 2023

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of DermTech, Inc.(DMTK) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire December 15, 2023

DMTK Deadline Alert: Bronstein, Gewirtz & Grossman LLC Reminds DermTech, Inc. Investors of Final Hours to Actively Participate in the Class Action Lawsuit!

Accesswire December 15, 2023

INVESTOR ALERT: Contact Levi & Korsinsky Before December 15, 2023 to Discuss Your Rights - DMTK

Accesswire December 15, 2023

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the Firm

Accesswire December 15, 2023